HBV DNA polymerase — Drug Target

All drugs that target HBV DNA polymerase — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Nucleoside analog reverse transcriptase inhibitor (NRTI) · Nucleotide reverse transcriptase inhibitor · nucleoside analogue

Marketed (1)

• Therapeutic entecavir · Taipei Veterans General Hospital, Taiwan · Nucleoside analog reverse transcriptase inhibitor (NRTI) · Infectious Disease
  Entecavir is a guanosine nucleoside analog that selectively inhibits the replication of hepatitis B virus (HBV) DNA polymerase.

Phase 2 pipeline (2)

• Adefovir tablets · GlaxoSmithKline · Nucleotide reverse transcriptase inhibitor · Infectious Disease
  Adefovir works by inhibiting the replication of the hepatitis B virus.
• Entecavir dispersible tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · nucleoside analogue · Infectious Disease
  Inhibits hepatitis B virus DNA polymerase